Trifork Group (TRIFOR) investor relations material

Executive summary

• Achieved 11% organic group revenue growth (ex-hardware) and 21% improvement in adjusted EBITDA, with margin rising to 10.8% in Q2 2026.

• Products segment delivered 23% organic revenue growth (ex-hardware), now representing 50% of group revenue and driving margin above 20%.

• Public sector revenue grew 33% year-over-year, now accounting for half of total revenue, with strong demand in e-health and sovereign data.

• Announced partial divestment of Labs assets to Verdane for EUR 23m, with plans for an extraordinary dividend of DKK 3/share and further portfolio realizations.

• Won 3 out of 4 public tenders in the last 12 months, with a strong pipeline in Denmark.

Financial highlights

• Q2 2026 revenue: EUR 58.2m, up 5.6% year-over-year; 6M 2026 revenue: EUR 114.3m.

• Adjusted EBITDA Q2: EUR 6.3m (margin 10.8%), up from EUR 5.2m (9.4%) in Q2 2025.

• EBIT Q2: EUR 2.2m (margin 3.8%), nearly doubling from EUR 1.1m (2.1%) last year.

• Net income Q2: EUR 0.6m (EPS EUR 0.01), up from EUR 0.1m (EPS EUR -0.01) in Q2 2025.

• Return on equity (LTM): 9.3%.

Outlook and guidance

• 2026 organic revenue growth guidance of 7–11%; adjusted EBITDA guidance of 16–33% growth, with a 15–17% margin.

• Full-year 2026 revenue guidance: EUR 230–240m; adjusted EBITDA EUR 35–40m.

• High activity expected in H2 2026, driven by Products and cost control.

• Hardware sales expected at least on par with 2025.

• Forward-looking guidance includes effects from announced acquisitions and divestments.